The regulated dephosphorylation of mitogen-activated protein kinases (MAPKs) plays a key role in determining the magnitude and duration of kinase activation and hence the physiological outcome of signalling. In mammalian cells, an important component of this control is mediated by the differential expression and activities of a family of 10 dual-specificity (Thr/Tyr) MAPK phosphatases (MKPs). These enzymes share a common structure in which MAPK substrate recognition is determined by sequences within an amino-terminal non-catalytic domain whereas MAPK binding often leads to a conformational change within the C-terminal catalytic domain resulting in increased enzyme activity. MKPs can either recognize and inactivate a single class of MAP kinase, as in the specific inactivation of extracellular signal regulated kinase (ERK) by the cytoplasmic phosphatase DUSP6/MKP-3 or can regulate more than one MAPK pathway as illustrated by the ability of DUSP1/MKP-1 to dephosphorylate ERK, c-Jun amino-terminal kinase and p38 in the cell nucleus. These properties, coupled with transcriptional regulation of MKP expression in response to stimuli that activate MAPK signalling, suggest a complex negative regulatory network in which individual MAPK activities can be subject to negative feedback control, but also raise the possibility that signalling through multiple MAPK pathways may be integrated at the level of regulation by MKPs.
Introduction
The mitogen-activated protein kinase (MAPK) cascades are conserved signal transduction pathways, which are activated in response to a diverse array of extracellular stimuli and can mediate both physiological and pathological responses in mammalian cells and tissues (Chang and Karin, 2001; Pearson et al., 2001; Dong et al., 2002; Wada and Penninger, 2004) . These include cell proliferation, differentiation and transformation, stress responses, inflammation, growth arrest and apoptosis. The three major MAPK pathways are the extracellular signal regulated kinases (ERKs) 1 and 2 that are activated in response to growth factors and hormones and two distinct subfamilies of MAPK that respond to conditions of cellular stress. These are the cJun amino-terminal kinases (JNKs 1-3) and the p38 MAPKs (a, b, g and d). The core MAPK signalling module consists of a three-tier kinase cascade in which a MAPK kinase kinase (MKKK or MEKK) phosphorylates and activates a MAPK kinase (MKK or MEK). The latter is a dual-specificity protein kinase that phosphorylates both the threonine and tyrosine residues of the conserved T-X-Y motif and activates the MAPK itself (Marshall, 1994) .
The physiological outcome of MAPK signalling depends on both the magnitude and duration of kinase activation (Marshall, 1995) . In addition, the spatial distribution of MAPK activity can markedly alter the output of signalling, presumably by regulating access to substrates, dependent on subcellular localization (Ebisuya et al., 2005) . The factors that influence the spatiotemporal regulation of MAPK signalling are both diverse and complex. They include the density and rates of internalization of cell surface receptors, the association of MAPK signalling components with scaffold proteins, and the balance between kinase activation and negative regulatory controls such as protein phosphatases (Volmat and Pouyssegur, 2001; Morrison and Davis, 2003; Murphy and Blenis, 2006) . This latter class of proteins is now known to play an important role in the regulation of MAPK signalling (Keyse, 2000; Saxena and Mustelin, 2000) . In particular, a family of 10 dualspecificity MAP kinase phosphatases (MKPs) acts to dephosphorylate and inactivate MAP kinase isoforms in mammalian cells. Certain MKPs are encoded by genes, which are transcriptionally upregulated by many stimuli that activate MAP kinase signalling. In addition, individual MKPs are able to differentially regulate MAPK isoforms. Thus, the MKPs form part of a complex negative regulatory network that acts to control MAPK pathway activities. This review explores the molecular mechanisms by which MKPs differentially recognize, bind and dephosphorylate MAP kinases and also discusses the evidence that has come from recent studies of MKP function which indicates that these enzymes play key roles in both the spatiotemporal regulation and integration of MAPK signalling.
The dual-specificity MKPs
The dual-specificity MKPs comprise a subfamily of 10 catalytically active proteins, all of which share a common structure comprising an N-terminal noncatalytic domain and a C-terminal catalytic domain Theodosiou and Ashworth, 2002) . The non-catalytic domain contains two regions of homology with sequences flanking the active site of the Cdc25 cell cycle regulatory phosphatase and this reflects the fact that this domain of the MKPs and Cdc25 are both structurally related to the Rhodanese family of sulphotransferases (Keyse and Ginsburg, 1993; Bordo and Bork, 2002) . The catalytic domain, which contains the characteristic cysteine-dependent protein tyrosine phosphatase active site sequence I/VHCXAGXXR, is related in sequence to the prototypic VH-1 dualspecificity phosphatase encoded by vaccinia virus Keyse, 2000) . Based on gene structure, sequence similarity and subcellular localization, the 10 MKPs can be subdivided into three classes (Theodosiou and Ashworth, 2002) . The first of these comprises DUSP1/MKP-1, DUSP2/PAC-1, DUSP4/ MKP-2 and DUSP5, all of which are inducible nuclear phosphatases. The second group comprises three closely related cytoplasmic phosphatases DUSP6/MKP-3, DUSP7/MKP-X and DUSP9/MKP-4 that preferentially inactivate ERK1 and ERK2. The third group comprises DUSP8, DUSP10/MKP-5 and DUSP16/ MKP-7 all of which show substrate selectivity towards the stress activated MAPK isoforms. Nomenclature and some basic properties of the MKPs are summarized in Table 1 .
Mechanisms of substrate recognition and catalysis
The first MKP demonstrated to exhibit substrate specificity for a particular MAPK isoform was the cytoplasmic phosphatase DUSP6/MKP-3, which inactivates ERK1/2 in vitro and in vivo whereas displaying little or no activity towards either JNK or p38 (Groom et al., 1996; Muda et al., 1996) . It was subsequently demonstrated that other MKPs such as DUSP8, DUSP10/MKP-5 and DUSP16/MKP-7 are able to selectively inactivate JNK and p38 but not ERK1/2 whereas others such as DUSP1/MKP-1 can regulate all three classes of MAPK (Muda et al., 1996; Tanoue et al., 1999 Tanoue et al., , 2001b Slack et al., 2001) . The specific recognition and binding of ERK2 by DUSP6/MKP-3 is mediated by a conserved motif within the aminoterminal non-catalytic domain of the protein and is accompanied by a significant increase in the catalytic activity of DUSP6/MKP-3 in vitro Muda et al., 1998) . Based on these observations, catalytic activation was proposed as a general mechanism governing substrate selectivity for the MKPs . This idea was supported by subsequent work demonstrating that the activity of several other MKPs including DUSP1/MKP-1, DUSP4/ MKP-2, DUSP7/MKP-X and DUSP9/MKP-4 is also increased on binding to their MAPK substrates. This is particularly striking in the case of DUSP1/MKP-1, which undergoes catalytic activation on binding to ERK, JNK and p38, thus reflecting the ability of this phosphatase to recognize and inactivate all three major classes of MAPK in vivo (Slack et al., 2001 ). Abbreviation: MKP, MAPK phosphatase.
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A major clue as to how the activity of MKPs is increased on binding to MAPKs came with the determination of the crystal structure of the catalytic domain of DUSP6/MKP-3 in the absence of substrate (Stewart et al., 1999) . This revealed that key catalytic residues within DUSP6/MKP-3 display a distorted geometry. In particular, a loop containing an aspartic acid residue (Asp262), which performs an essential role as a general acid, is displaced such that it is 5.5 Å away from the position of the equivalent residue in the related dual-specificity phosphatase VHR, and thus unlikely to participate in catalysis. This is consistent with a model in which ERK binding causes a conformational change within the catalytic domain of DUSP6/MKP-3 involving closure of the general acid loop over the active siteand positioning Asp262 for catalysis. This was confirmed by a combination of site directed mutagenesis and biochemical studies in which Asp262 was found to function as a general acid only in the presence of ERK2 (Stewart et al., 1999; Zhou and Zhang, 1999; Rigas et al., 2001) . More recently, the structures of DUSP10/ MKP-5 and DUSP5 have also been obtained. Interestingly, unlike DUSP6/MKP-3, neither of these enzymes undergo catalytic activation on binding to their physiological MAPK substrates (Tanoue et al., 1999; Mandl et al., 2005) and in both structures the mobile loop containing the general acid residue is already positioned optimally for catalysis (Jeong et al., 2006a, b) . This is consistent with biochemical studies indicating that the intrinsic catalytic activity of DUSP5 is actually higher than that of DUSP6/MKP-3 in the presence of ERK2 and that the general acid residue of DUSP5 is essential for this activity (Mandl et al., 2005 The specific recognition of ERK2 by DUSP6/MKP-3 requires a cluster of positively charged residues within the amino-terminal non-catalytic domain. Mutation of Arg64 and Arg65 within this kinase interaction motif (KIM) is sufficient to prevent dephosphorylation of ERK2 by DUSP6/MKP-3 . This KIM is proposed to interact with negatively charged aspartic acid residues (Asp316 and 319) within a common docking (CD) site identified as an essential mediator of protein-protein interactions between MAPKs and their activators, regulators and substrates (Tanoue et al., 2000) . It was quickly realized that the KIM was a conserved feature found within the aminoterminal domain of all dual-specificity MKPs ( Figure 1 ) and attention focused on this region of the MKPs in determining the differential binding of these proteins to MAPK isoforms. One early clue that distinct binding determinants exist for ERK, JNK and p38 MAP kinases came with the finding that mutation of the conserved KIM within the nuclear phosphatase DUSP1/MKP-1 prevented binding to ERK and p38, but did not affect the ability of this phosphatase to recognize and inactivate JNK (Slack et al., 2001) . Similar results were reported for the closely related enzyme DUSP4/MKP-2 (Chen et al., 2001) .
In parallel, it was realized that the CD site within MAPKs is not the only determinant of specific interactions with partner proteins. A second motif, the ED site, was identified within ERK2 and p38, which also contributes to the specificity of interactions between these MAPKs and binding partners including MKPs (Tanoue et al., 2001a) . The solution of a crystal structure for p38 MAPK in complex with peptides derived from MEF2A, a p38 substrate, and MKK3, a p38 activator, further defined the interaction surface on the MAPKs by identifying an extended docking groove (DG) and also demonstrated that there were significant differences between interactions with substrates and activators (Chang et al., 2002) . With respect to the MKPs themselves, closer examination of the sequences adjacent to the KIM (Arg 53, 54 and 55) in DUSP1/MKP-1 revealed a second motif comprising Arg 72 and 74 surrounded by hydrophobic residues (Figure 1 ). Site-directed mutagenesis revealed that this motif was important for the ability of DUSP1/ MKP-1 to interact with JNK rather than p38 and, based on its positive charge, it was postulated to be the site of interaction with the negative residues of the ED site (Tanoue et al., 2002) . A comparison of this extended docking region within DUSP1/MKP-1 with the corresponding sequences present in other MKPs led to the identification of a further area of conservation lying between the KIM and Arg72/74, which is abundant in hydrophobic residues (Figure 2 ). Mutation of either Met60 and Leu62 or Ile65 and Val66 to alanine caused loss of MKP-1 binding to both JNK and p38 indicating that this region is crucial for recognition of these kinases. Overall these studies suggest that the docking surface contained within the amino-termini of the MKPs is modular and that sequence variations with respect to position, number and species of charged amino acids within each module define the ability of MKPs to differentiate between and bind to specific MAPK isoforms (Tanoue et al., 2002) .
Satisfyingly, a recent study in which a structure has been obtained for ERK2 in complex with the KIM peptide from DUSP6/MKP-3 confirms the primacy of the contacts between the basic residues of the KIM motif in mediating the interaction between these proteins . In particular, it identifies Arg65 of DUSP6/MKP-3 and Asp319 of ERK2 as providing the vast majority of side chain contacts in the ERK2-DUSP6/MKP-3 complex. This latter result is entirely consistent with previous biochemical and genetic studies where mutation of Arg65 causes a dramatic reduction in the affinity of DUSP6/MKP-3 for ERK2 and mutation of Asp319 to Asn in the sevenmaker gain of function mutant in Drosophila ERK/Rolled results in resistance of ERK to inactivation by protein phosphatases (Bott et al., 1994; Chu et al., 1996; Nichols et al., 2000) . With respect to potential determinants of docking specificity, this study reinforces the concept that although MAP kinases may employ a Figure 2 Surface representation of distinct docking domains on rat ERK2 (coordinates from www.rcsb.org), which are bound by the KIM and putative F-X-F-P motifs of MKP-3. Surface residues identified by reduced rates of hydrogen/deuterium (H/D) exchange and which have also been identified as important in binding to the KIM motif of MKP-3 are coloured red. The critical aspartic acid residues 316 and 319, which fall within this protected region and form primary contacts with Arg 64 and 65 within the KIM motif are coloured purple. On the opposite face of the larger C-terminal lobe of ERK2 residues that exhibit lower rates of H/D exchange in the presence of MKP-3 are coloured yellow and residues within this protected region which are essential for binding to the DEF (docking site for ERK, F/Y-X-F/Y-P) motifs of Elk-1 and c-Fos are coloured brown. A model is proposed in which the KIM of MKP-3 binds to the region containing Asp 316 and 319 whereas catalytic activation of MKP-3 is dependent on additional contacts between the putative F-X-F-P motif (FTAP) within the C-terminus of MKP-3 and the DEF docking domain.
common docking site for the KIM within MKPs, there are significant variations in the residues which are in direct contact with these motifs and which ensure binding specificity . How then, once a MAPK substrate is engaged by an MKP, is binding linked to productive orientation of catalytic residues within the active site? To date, the structural basis of this phenomenon has been elusive as no crystal structure for a complete MKP has been solved and co-crystals of MAPK in complex with substrate proteins have proven extremely difficult to obtain. An NMR structure has been published for the isolated amino-terminal ERK-binding (EB) domain of DUSP6/MKP-3 (Farooq et al., 2001) . This revealed the predicted structural homology between this domain of MKPs, the catalytic domain of the Cdc-25 cell cycleregulatory phosphatase and the rhodanese family of cysteine-dependent sulphotransferases and site-directed mutagenesis confirmed the importance of key residues within the KIM of DUSP6/MKP-3, for ERK2 binding (Farooq et al., 2001) . In an attempt to probe the functional coupling between the EB and catalytic domains of DUSP6/MKP-3 NMR binding studies were performed using the catalytic domain of the related enzyme DUSP2/PAC-1, which is similar in structure to DUSP6/MKP-3 (Farooq et al., 2003) . Although the binding affinity of the two recombinant domains is relatively weak when compared to the binding of the EB domain to ERK2, these experiments reveal that the EB domain may utilize overlapping regions for its interaction with either its C-terminal catalytic domain or ERK2 and that the contacts between the EB and catalytic domains involve both sequences near the active site and within the extreme C-terminus of DUSP6/ MKP-3. Overall these results, combined with the observation that the catalytic domain of DUSP6/ MKP-3 alone has very low phosphatase activity, would argue that the EB does not suppress the activity of DUSP6/MKP-3 by autoinhibition, but instead participates in a mechanism of substrate -induced activation (Farooq et al., 2001) .
To gain further insights into the molecular basis of the specific ERK2 recognition by DUSP6/MKP-3, the technique of hydrogen/deuterium exchange mass spectrometry (H/DX-MS) has recently been employed to map the interface between these two proteins . This technique relies on the propensity of amide protons within the peptide bonds of the protein to exchange with those of the solvent. If the latter is D 2 O rather than H 2 O, the corresponding mass change can then be used to determine relative solvent accessibility. To analyse protein-protein interactions, the exchange reaction is carried out with the individual proteins and the complex and the regions of exchange compared. If a sequence is buried as a result of binding, the amides are protected, thus revealing the interaction interface (Mandell et al., 1998) . Consistent with previous structural data, the KIM within DUSP6/MKP-3 (residues 64-76) displayed strong solvent protection as evidenced by a reduced rate of deuterium incorporation. In addition, residues between Tyr98 and Leu115, a segment which had not previously been implicated in mediating ERK2 binding, also displayed solvent protection. One drawback of H/DX-MS is an inability to distinguish between solvent inaccessibility owing to bona fide protein-protein interaction and that caused by conformational change within the protein structure. However site-directed mutagenesis coupled with in vitro binding studies using GST-pulldown assays confirms that substitution of either Leu97 or Asn106 abrogates ERK2 binding, indicating a role for this sequence in substrate recognition .
With regard to the C-terminal catalytic domain of DUSP6/MKP-3, a major surprise was the extent of the reduction in H/D exchange rates throughout this region. This is unlikely to reflect direct protein contact, and mutagenesis of a number of surface exposed residues within this domain confirms that they play no role in mediating interactions with ERK2 . Thus, it is more likely that reduced rates of exchange reflect an overall decrease in protein dynamics and flexibility. This is consistent with an ERK-induced conformational change. Finally, a putative F-X-F-P ERK docking motif (FTAP, residues 364-367) within the C-terminal tail of DUSP6/MKP-3 also displayed reduced deuterium incorporation. This sequence was not present in the truncated domain used for structural determination (Stewart et al., 1999) , but biochemical studies had previously indicated that although this motif was not essential for ERK binding, it was required for ERK-induced activation of DUSP6/MKP-3 (Zhou et al., 2001) .
With respect to ERK2 itself, contacts with DUSP6/ MKP-3 were identified, which correspond to the CD domain and DG and are thus are in agreement with both structural data and mutagenesis experiments (Figure 2 ). In addition, strong solvent protection was observed in three segments Phe166-Leu198, Leu220-Glu248 and Ile253-Leu262. These sequences include the T-X-Y signature phosphorylation motif (residues 183-185) in the activation loop of ERK2 and also sequences within the MAP kinase insert . Interestingly, this latter region was also identified as essential for the binding of proteins containing DEF (docking site for ERK, F/Y-X-F/Y-P) motifs such as the Ets family transcription factor Elk-1 and c-Fos (Dimitri et al., 2005) and these peptides were also identified as exhibiting reduced H/D exchange in an independent study using an F-X-F-P-containing peptide derived from the Elk-1 transcription factor (Lee et al., 2004) . Mutation of residues in the DEF domain binding pocket of ERK2 (Lys257 and Tyr261 to Ala) did not affect binding to DUSP6/MKP-3, but did cause a reduction in catalytic activation of the phosphatase by as much as 85%. Taken together, these results allow the formulation of a model in which a primary interaction between the KIM containing peptide of DUSP6/MKP-3 and the CD domain of ERK coupled with additional contacts involving the FTAP motif of DUSP6/MKP-3 and the ERK DEF-binding pocket combine to effect allosteric activation of the phosphatase (Figure 2) . Although these studies offer a tantalizing glimpse of the possible mechanisms with respect to MKP-3 substrate recognition and catalytic activation, it remains to be demonstrated that this bipartite model of binding is more generally applicable to the substrate interactions of other MKPs. The final resolution of these questions may only be possible when structural information for complexes between MAPKs and MKPs becomes available.
MKPs play essential roles in a wide range of physiological processes
The ability of dual specificity MKPs to differentially bind and inactivate MAPK isoforms has the potential to significantly modify the biological outcome of signalling. However, despite our knowledge of the mechanisms underlying substrate recognition and catalysis, the physiological roles of MKPs are largely unexplored. An initial genetic experiment in which the murine DUSP1/ MKP-1 gene was knocked out failed to detect any obvious phenotype in either the null animals or cells derived from them (Dorfman et al., 1996) . These results were interpreted, as indicating that either DUSP1/ MKP-1 did not play a significant role in regulating MAPK activity or there is a significant degree of functional redundancy within the MKP subfamily. However, reappraisal of the DUSP1/MKP-1 null mice combined with additional mouse knockouts and developmental studies have begun to demonstrate interesting and often unexpected roles for the MKPs in regulating a number of physiological processes. These include immune and metabolic function, the regulation of stress responses and development.
MKPs and the regulation of immune function
Mouse knockout experiments have now demonstrated that three MKPs play essential non-redundant roles in regulating immune function. These are DUSP1/MKP-2, DUSP2/PAC-1 and DUSP10/MKP-5. Although mice lacking either DUSP1/MKP-1 or DUSP10/MKP-5 show no developmental defects with respect to the immune system, both animals have defects in innate and adaptive immunity. In the case of DUSP1/MKP-1, null animals are sensitized to lethal endotoxic shock and exhibit a marked increase in incidence and severity of experimentally induced autoimmune arthritis (Chi et al., 2006; Hammer et al., 2006; Salojin et al., 2006; Zhao et al., 2006) . This is accompanied by the overproduction of both pro-and anti-inflammatory cytokines (Figure 3a) . At the cellular level, macrophages from the null animals show increased p38 and JNK MAPK activities in response to bacterial lipopolysaccharide (LPS). With respect to cytokine production, at early times after exposure to LPS DUSP1/MKP-1 null macrophages produce increased levels of the proinflammatory cytokine tumour necrosis factor (TNF) when compared with wild-type cells. In contrast, production of the anti-inflammatory cytokine interleukin (IL)-10 is both immediate and prolonged in duration (Chi et al., 2006) .
The expression of DUSP10/MKP-5 is strongly induced in macrophages exposed to LPS. In the T-cell compartment, expression of DUSP10/MKP-5 is constitutive in naı¨ve cells but downregulated following T-cell activation. In DUSP10/MKP-5 null animals, elevated JNK activities are seen in both T-cells and also in macrophages exposed to LPS whereas p38 activity appears to be unaffected (Zhang et al., 2004) . Thus, the major role of DUSP10/MKP-5 appears to be the regulation of JNK activity during innate or adaptive immune responses. As was seen in the DUSP1/MKP-1 null mice, macrophages lacking DUSP10/MKP-5 overproduce proinflammatory cytokines when exposed to LPS (Figure 3b) . However, in the T-cell compartment the picture is more complex. Firstly antigen-presenting cells from DUSP10/MKP-5 null animals exhibit increased T-cell priming activity following exposure to LPS. However, despite the overproduction of both T-helper cell 1 and T-helper cell 2 (Th1 and Th2) cytokines, T-cell proliferation is impaired. The latter effect probably accounts for the resistance of DUSP10/ MKP-5 null mice to experimental autoimmune encephalitis following injection of myelin oligodendrocyte glycoprotein. A positive role for DUSP10/MKP-5 in T-cell expansion is consistent with previous studies indicating that JNK itself plays an inhibitory role in T-cell growth (Dong et al., 1998) . In terms of T-cellmediated immunity, DUSP10/MKP-5 null mice show little difference in primary response to infection with lymphocytic choriomeningitis virus (LCV) when compared to wild-type animals. However, secondary exposure to LCV causes significant immune-mediated lethality among DUSP10/MKP-5 null mice. This is most probably associated with the high levels of serum TNF seen after viral challenge (Zhang et al., 2004) . The third MKP, which plays a key role in regulating immune function, is DUSP2/PAC-1. This gene was originally characterized as encoding a mitogen-induced phosphatase in human T cells and its induction appears to dependent on the activation of ERK1 and 2, suggesting that it functions as part of a negative feedback control of MAPK activity (Rohan et al., 1993; Grumont et al., 1996) . With respect to substrate specificity, PAC-1 can dephosphorylate ERK and p38 in vitro and in vivo, but only ERK appears to cause catalytic activation of DUSP2/PAC-1 in vitro (Chu et al., 1996; Zhang et al., 2005) . DUSP2/PAC1 was also identified as a p53 target gene in fibroblasts following oxidative stress and small interfering RNAmediated knockdown of DUSP2/PAC1 correlated with increased ERK activation and protected cells from apoptosis (Yin et al., 2003) . Despite this apparent specificity for ERK and p38, the results of a recent gene knockout for DUSP2/PAC-1 have revealed considerable complexity in the regulation of MAPK activities by this phosphatase and uncovered an unexpected role for DUSP2/PAC-1 as a positive regulator of inflammatory responses (Jeffrey et al., 2006) . Firstly, DUSP2/PAC-1 null mice display much reduced levels of inflammation in an autoimmune model of rheumatoid arthritis where disease progression is dependent on effector leucocytes such as macrophages mast cells and neutrophils. At the cellular level, LPS-stimulated DUSP2/PAC-1 null macrophages also produce much lower levels of proinflammatory cytokines and chemokines when compared with wild-type cells (Figure 3c) . Furthermore, despite the expectation that DUSP2/PAC-1 loss would result in increased activation of ERK and possibly p38, the deficit in synthesis of inflammatory mediators is accompanied by a decrease in ERK and p38 activities and an increase in JNK activation (Jeffrey et al., 2006) . The downregulation of ERK appears to be the result of crosstalk with JNK as pharmacological inhibition of JNK increases ERK activity.
What then is the mechanistic basis for the nonredundant functions of these MKPs in immune regulation? In the case of DUSP1/MKP-1 and DUSP10/ MKP-5, a key factor may be the extent to which these two MKPs influence the activities of different MAPK pathways. The major target of MKP-1, at least in macrophages, appears to be p38. Consistent with this, the overproduction of cytokines and inflammatory mediators seen in DUSP1/MKP-1 null macrophages is suppressed by SB203580, a specific p38 inhibitor of p38 (Chi et al., 2006; Hammer et al., 2006) . In contrast, loss of DUSP10/MKP-5 results in increased JNK activity with little of no change seen in p38 activation (Zhang et al., 2004) . Another key factor may be the spatial restriction of MKP activity. Unlike DUSP10/MKP-5, which is found in both the nucleus and the cytoplasm (Tanoue et al., 1999) , DUSP1/MKP-1 is a nuclear enzyme and may act differentially to regulate nuclear but not cytoplasmic MAPK functions (Wu et al., 2005) . Support for the latter idea has come from a recent study, again using null mice, in which DUSP1/MKP-1 was identified as a key regulator of metabolic homoestasis . Mice lacking DUSP1/MKP-1 do not gain weight when fed either normal chow or on a highfat diet when compared with wild-type animals. Resistance to diet-induced obesity is accompanied by complex changes in the activities of ERK, JNK and p38 in insulin responsive tissues. Elevated JNK and p38 activation is seen in liver, white adipose tissue (WAT) and skeletal muscle, whereas increased ERK activity is seen in WAT and muscle, but not in liver. In the latter tissue, there is very good evidence that phosphorylation of nuclear JNK targets such as c-Jun is increased, whereas the phosphorylation of insulin receptor substrate-1, a cytoplasmic target of JNK, is unaffected . Thus, the spatial restriction of DUSP1/ MKP-1 activity, as well as its ability to differentially regulate the three major MAPK pathways, may underpin the unique aspects of the DUSP1/MKP-1 knockout with respect to immune and metabolic functions.
Although the effects of removing either DUSP1/ MKP-1 or DUSP10/MKP-5 can be rationalized with previous results of biochemical and transfection experiments in terms of MAPK substrate preferences, the changes in MAPK activities seen on DUSP2/PAC-1 deletion are unexpected. Expression studies have demonstrated that DUSP2/PAC-1 inactivates ERK and p38 but not JNK in vitro and in vivo (Chu et al., 1996) . Further studies of DUSP2/PAC-1 function in immune effector cells will be required to elucidate the mechanism by which this MKP is able to target JNK and also the exact nature of the interactions which lead to suppression of ERK and p38 activities.
Cytoplasmic ERK-specific MKPs play essential roles during early development The closely related phosphatases DUSP6/MKP-3, DUSP7/MKP-X and DUSP9/MKP-4 constitute a subgroup of cytoplasmic MKPs that exhibit substrate selectivity towards ERK1 and 2 MAPKs (Table 1) . DUSP9/MKP-4 was the first member of this group of MKPs to be analysed by gene deletion. Mice lacking DUSP9/MKP-4 die in utero from placental insufficiency, which is secondary to a failure of labyrinth development (Christie et al., 2005) . Based on biochemical evidence and transfection experiments, the most likely substrates for DUSP9/MKP-4 in vivo are ERK1 and 2 and/or p38 MAPK (Dickinson et al., 2002b) . However, no significant abnormalities in the phosphorylation levels of either of these MAPKs were observed in null placental tissues when compared with wild type (Christie et al., 2005) . This may indicate that these enzymes are not targeted by DUSP9/MKP-4. Alternatively, the signalling abnormality may either be very transient or of such low magnitude to make its detection difficult. Interestingly, deletion of either p38a or MEK1 (the upstream activator of ERK) leads to placental defects that are almost identical to those seen on deletion of DUSP9/MKP-4 (Giroux et al., 1999; Adams et al., 2000) , a possible indication that these MAPKs may indeed be targets for this phosphatase. Although necessary for placental development and function, tetraploid rescue experiments demonstrate that DUSP9/MKP-4 is entirely dispensable for normal embryogenesis. Furthermore, organs such as liver, kidney and testis, in which DUSP9/MKP-4 is expressed either during development or in the adult, exhibit normal tissue morphology in mice lacking DUSP9/ MKP-4 (Christie et al., 2005) .
The ERK-specific phosphatase DUSP6/MKP-3 is by far the most studied of this group of three cytoplasmic MKPs. The first clue as to a physiological function for DUSP6/MKP-3 came with the observation that it is expressed at many sites of fibroblast growth factor (FGF) signalling during early mouse development (Dickinson et al., 2002a) . Subsequent studies in the developing limbs and nervous tissues in chicken embryos demonstrated that DUSP6/MKP-3 expression was mediated by FGFs as a component of a negative feedback control to regulate levels of activated ERK MAPK in these tissues (Eblaghie et al., 2003; Kawakami et al., 2003) . There is currently some confusion as to which of the intracellular signalling pathways that lie downstream of the FGF-receptor is responsible for mediating DUSP6/MKP-3 expression, with evidence supporting a role for either ERK MAPK or PI3-kinase signalling in this process (Eblaghie et al., 2003; Kawakami et al., 2003; Tsang et al., 2004; Gomez et al., 2005; Smith et al., 2005) . Most of these data were obtained using different pharmacological inhibitors of the ERK pathway and this may explain some of the apparently contradictory results (Smith et al., 2006) .
Overexpression of DUSP6/MKP-3 in either the chicken limb or neural plate causes abnormalities in these tissues, whereas either overexpression or morpholino-mediated knockdown of DUSP6/MKP-3 in zebrafish embryos causes profound defects in dorsoventral patterning (Eblaghie et al., 2003; Tsang et al., 2004) . This is presumably because DUSP6/MKP-3 acts to maintain FGF-mediated ERK activities at levels that are permissible for normal tissue growth and development.
Support for such a role has now come with, the result of a mouse knockout for DUSP6/MKP-3 (Li et al., 2007) . Surprisingly, given the severity of the defects seen following morpholino-mediated knockdown of DUSP6/MKP-3 in Zebrafish embryos, mouse embryos lacking this phosphatase do not present with any obvious abnormalities. However, embryos lacking DUSP6/MKP-3 do show evidence of increased levels of phosphorylated ERK2 in the limb buds and present with a variably penetrant postnatal lethality, skeletal dwarfism, premature fusion of the cranial sutures (craniostynostoses) and hearing loss (Li et al., 2007) . All of these features are consistent with increased activity of FGF receptor (FGFR)-mediated signalling pathways although they do not precisely mimic the results of any particular FGF receptor gain of function mutant. This together with the incomplete penetrance of the phenotype suggests that DUSP6/MKP-3 may function downstream of more than one FGFR and that there may also be some degree of redundancy between DUSP6/MKP-3 and other negative regulators of FGF signalling, including the closely related phosphatases DUSP7/MKP-X and DUSP9/MKP-4 (Li et al., 2007) .
Conclusions
With respect to the differential recognition and dephosphorylation of MAPKs by dual-specificity MKPs, we understand some details of the molecular mechanisms involved, but questions still remain. Principal among these are the full extent of the binding interactions between MKP and MAPK, which must determine substrate selectivity, and the precise way in which conformational change within the catalytic domain of MKPs occurs, leading to increased activity. In addition, MKPs such as DUSP5 and DUSP10/MKP-5 do not undergo catalytic activation in vitro on binding to substrate MAPKs, indicating that these enzymes rely on specific protein-protein interactions alone to determine substrate selectivity. It could be argued that assaying catalytic activation using the chromogenic substrate para-nitrophenyl phosphate is not physiological and could be misleading. However, the crystal structures of the catalytic domains of both DUSP5 and DUSP10/ MKP-5 show that, unlike DUSP6/MKP-3, these enzymes adopt a catalytically favourable geometry in the absence of substrate. Why certain MKPs require secondary conformational change on substrate binding to be fully active, whereas others do not, is unclear.
How the differential activity of MKPs is expressed in physiological terms is becoming more apparent with the generation of mice lacking individual MKP genes. Thus far, it is clear that the ability of MKPs such as DUSP1/ MKP-1 to regulate at least three classes of MAPK in mammalian cells is critical to its ability to perform distinct and important functions in the immune system and in the regulation of metabolic homoeostasis. This suggests that signalling through multiple MAPK pathways may be integrated at the level of MKP expression.
Furthermore, it is also clear that the spatial restriction of MKP activity may be critical in determining outcome as exemplified by the ability of DUSP1/MKP-1 to inactivate the nuclear as opposed to cytoplasmic pool of JNK. The recent finding that both DUSP8 and DUSP16/MKP-7 can bind to the JNK scaffold proteins JNK-interacting protein-1 and b-arrestin 2 indicates that the spatial restriction of the activities of MKPs will be an increasingly important component of their function (Willoughby et al., 2003; Willoughby and Collins, 2005) . Finally, the phenotypes observed following ablation of certain MKPs such as DUSP1/MKP-1, DUSP10/MKP-5 and DUSP6/MKP-3 are consistent with previous biochemical and overexpression studies in terms of MAPK regulation. In contrast, studies of DUSP9/MKP-4 null animals have not yet led to an unequivocal linkage between the activity of this MKP and target MAPK pathways. In the case of mice lacking DUSP2/PAC-1, the changes seen in the activities of individual MAPKs are unexpected given the results of previous work to determine the cellular targets for this phosphatase. Future studies will be directed towards the resolution of these questions and when combined with the generation of additional mouse knockout models should lead to a comprehensive understanding of MKP function in both normal physiology and disease.
